ProCE Banner Activity

CROI 2021: Highlights From Data on Emerging Treatment Options

Clinical Thought
Emerging HIV treatment options were at the forefront of CROI 2021. Here are my key takeaways from some of the most intriguing presentations.

Released: April 06, 2021

Expiration: April 05, 2022

Share

Faculty

Danielle Roman

Danielle Roman, PharmD, BCOP

Manager, Clinical Pharmacy Services
Allegheny Health Network
Pittsburgh, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare

Faculty Disclosure

Primary Author

Danielle Roman, PharmD, BCOP

Manager, Clinical Pharmacy Services
Allegheny Health Network
Pittsburgh, Pennsylvania

Daniel R. Kuritzkes, MD, has reported that he has received funds for research support from Atea, Gilead Sciences, Merck, Novartis, and ViiV Healthcare and consulting fees from Abpro, Atea, Decoy, Gilead Sciences, GlaxoSmithKline, Merck, Rigel, and ViiV Healthcare.